Siemens Healthineers plans to spin off In Vitro Diagnostics business

Siemens Healthineers announced it is initiating a carve-out of its In Vitro Diagnostics business, a strategic shift in its portfolio structure. Further details on the structure and timeline of the spin-off are expected as the separation process progresses.

Detected & updated continuously · Source: Nebula